Trending...
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- New Mobile Car Detailing Platform Connects Drivers with On-Demand Local Pros
- Cal State LA secures funding for two artificial intelligence projects from CSU
Download
Geographical Analysis of Xylazine Use Among Individuals Who Use Fentanyl - Rate by U.S. Census Divisions. (Graphic: Business Wire)
SAN DIEGO--(BUSINESS WIRE)--According to the Millennium Health Signals Report released today, the powerful, veterinary tranquilizer xylazine—also known as "tranq"—was detected in urine drug tests from every region of the country, with the highest rates in the Eastern U.S. This analysis of the nationwide spread of xylazine is the most current and substantiative to date since xylazine use rose to prominence.
More on The Californer
"Increased awareness of the threats posed by xylazine is needed among clinicians and public health officials across the U.S. and geographical changes in xylazine use should be monitored closely with timely and reliable sources of surveillance data," says Scott Walton, CEO. "Although xylazine use among those who use fentanyl is currently concentrated in the East, a 2022 DEA report suggested that xylazine appears to be following the same east-to-west path as fentanyl. Time will tell if this becomes the case. We will continue to closely monitor xylazine and provide real-time updates about any shifting use as part of our commitment to help prevent drug overdose deaths."
According to Leonard Kamen, DO, Clinical Associate Professor of Physical Medicine and Rehabilitation, Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, "Xylazine has devastated our local community. The challenges it has brought are many because at present there are no treatments specifically approved for xylazine use nor any xylazine-specific overdose reversal agents approved for xylazine-involved overdoses. Clinicians should carefully monitor patients who report unusual drug effects when taking what they thought was fentanyl, or those who have the telltale skin wounds associated with xylazine use."
Xylazine-Associated Polysubstance Use Rates are Significant
The report also identified that the use of multiple substances (i.e., polysubstance use) is significantly higher among those testing positive for fentanyl and xylazine compared to those who had used fentanyl but not xylazine. Specifically, prescription opioid, heroin, gabapentin, benzodiazepine, cocaine, fentanyl analogue, and methamphetamine use were all greater among those who had used fentanyl and xylazine.
"This is a substance no human being was meant to ingest and often people may be exposed to it without their knowledge, which increases the risk. Though the effects of xylazine cannot be reversed using naloxone, xylazine often is used alongside opioids, which naloxone can reverse, so it should be administered in a suspected overdose," said Chief Clinical Officer Dr. Angela G. Huskey at Millennium Health. "This is a dangerous situation, and it's spreading rapidly. We are trying to sound the alarm on the need to integrate clinical monitoring into our national response so we can provide advance warning and know in real-time where people need help."
The Millennium Health Signals Report™ provides a summary of America's epidemic of illicit drug use and originates from Millennium Health's Emerging Threat Intelligence (ETI) Program™. The ETI program provides real-time surveillance of drug use trends to help clinicians, researchers, public health officials, and policymakers address the significant increase in drug overdose deaths.
More on The Californer
Methodology
The Millennium Health Signals Report: Zeroing in on Xylazine: The First 100 Days After U.S. Emerging Threat Designation is an analysis of urine drug test results from more than 160,000 specimens collected between April 12th and July 20th, 2023. Millennium Health analyzed Xylazine UDT positivity in the fentanyl using population by U.S. Census Division. Co-detection of 9 illicit or non-prescribed drug classes with and without xylazine was also evaluated. U.S. Census Regions and Millennium Health statistical methods are available upon request.
A copy of the full report can be accessed here.
About Millennium Health
Millennium Health is an accredited specialty laboratory providing medication monitoring via definitive urine and oral fluid drug tests to support improved clinical decision-making as part of treatment for millions of Americans with chronic pain, mental illness, substance use disorders, and other health conditions. Drug testing (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.millenniumhealth.com%2Ffor-clinicians%2Fdrug-test-offerings%2F&esheet=53554743&newsitemid=20230913825526&lan=en-US&anchor=Drug+testing&index=5&md5=ee6693c14e46e8321efe04fd9476b15e) is used to obtain objective information about patients' recent use of prescription medications and/or illicit drugs and helps monitor the effectiveness of treatment plans. We also conduct real-time tracking of emerging drug use trends (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.millenniumhealth.com%2Fsignalsreport%2F&esheet=53554743&newsitemid=20230913825526&lan=en-US&anchor=drug+use+trends&index=6&md5=2215a5938b8309d7847f09e2835bb65e) to help researchers, public health officials, and policymakers address the significant increase in drug overdose deaths.
Contacts
Jody Schneider
Millennium Health
Jody.Schneider@millenniumhealth.com
619-917-6810
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Contacts
Jody Schneider
Millennium Health
Jody.Schneider@millenniumhealth.com
619-917-6810
Geographical Analysis of Xylazine Use Among Individuals Who Use Fentanyl - Rate by U.S. Census Divisions. (Graphic: Business Wire)
- Geographical Analysis of Xylazine Use Among Individuals Who Use Fentanyl - Rate by U.S. Census Divisions. (Graphic: Business Wire)
SAN DIEGO--(BUSINESS WIRE)--According to the Millennium Health Signals Report released today, the powerful, veterinary tranquilizer xylazine—also known as "tranq"—was detected in urine drug tests from every region of the country, with the highest rates in the Eastern U.S. This analysis of the nationwide spread of xylazine is the most current and substantiative to date since xylazine use rose to prominence.
More on The Californer
- Blake Harris the Leading Authority in International Asset Protection Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- Wise Business Plans Emerges as a Go-To Partner for Angel Investors, VCs, Family Offices and Private
- Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science
- Neurocrine Biosciences Presents One-Year Data Showing Sustained Efficacy of CRENESSITY® (crinecerfont) in Adult Patients, at ENDO 2025
- Mike Diamond Offers $775 Off Full Heating & A/C Installation for a Limited Time
"Increased awareness of the threats posed by xylazine is needed among clinicians and public health officials across the U.S. and geographical changes in xylazine use should be monitored closely with timely and reliable sources of surveillance data," says Scott Walton, CEO. "Although xylazine use among those who use fentanyl is currently concentrated in the East, a 2022 DEA report suggested that xylazine appears to be following the same east-to-west path as fentanyl. Time will tell if this becomes the case. We will continue to closely monitor xylazine and provide real-time updates about any shifting use as part of our commitment to help prevent drug overdose deaths."
According to Leonard Kamen, DO, Clinical Associate Professor of Physical Medicine and Rehabilitation, Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, "Xylazine has devastated our local community. The challenges it has brought are many because at present there are no treatments specifically approved for xylazine use nor any xylazine-specific overdose reversal agents approved for xylazine-involved overdoses. Clinicians should carefully monitor patients who report unusual drug effects when taking what they thought was fentanyl, or those who have the telltale skin wounds associated with xylazine use."
Xylazine-Associated Polysubstance Use Rates are Significant
The report also identified that the use of multiple substances (i.e., polysubstance use) is significantly higher among those testing positive for fentanyl and xylazine compared to those who had used fentanyl but not xylazine. Specifically, prescription opioid, heroin, gabapentin, benzodiazepine, cocaine, fentanyl analogue, and methamphetamine use were all greater among those who had used fentanyl and xylazine.
"This is a substance no human being was meant to ingest and often people may be exposed to it without their knowledge, which increases the risk. Though the effects of xylazine cannot be reversed using naloxone, xylazine often is used alongside opioids, which naloxone can reverse, so it should be administered in a suspected overdose," said Chief Clinical Officer Dr. Angela G. Huskey at Millennium Health. "This is a dangerous situation, and it's spreading rapidly. We are trying to sound the alarm on the need to integrate clinical monitoring into our national response so we can provide advance warning and know in real-time where people need help."
The Millennium Health Signals Report™ provides a summary of America's epidemic of illicit drug use and originates from Millennium Health's Emerging Threat Intelligence (ETI) Program™. The ETI program provides real-time surveillance of drug use trends to help clinicians, researchers, public health officials, and policymakers address the significant increase in drug overdose deaths.
More on The Californer
- Mike Diamond Offers $99 Drain Cleaning to Help Los Angeles Homeowners Save
- GreenPal Empowers Lawn Care Pros Leveraging AI, Surpasses 5 Million Transactions
- Bilingual Children's Book Where Nopalitos Grow Added to Los Angeles Public Library Collection
- Bennett Awards Crafts Prestigious Custom Gold Trophies for VidCon's Inaugural Hall of Fame
- Santa Monica Businesses Push Back on Bus Stop Relocation That Threatens Access and Safety
Methodology
The Millennium Health Signals Report: Zeroing in on Xylazine: The First 100 Days After U.S. Emerging Threat Designation is an analysis of urine drug test results from more than 160,000 specimens collected between April 12th and July 20th, 2023. Millennium Health analyzed Xylazine UDT positivity in the fentanyl using population by U.S. Census Division. Co-detection of 9 illicit or non-prescribed drug classes with and without xylazine was also evaluated. U.S. Census Regions and Millennium Health statistical methods are available upon request.
A copy of the full report can be accessed here.
About Millennium Health
Millennium Health is an accredited specialty laboratory providing medication monitoring via definitive urine and oral fluid drug tests to support improved clinical decision-making as part of treatment for millions of Americans with chronic pain, mental illness, substance use disorders, and other health conditions. Drug testing (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.millenniumhealth.com%2Ffor-clinicians%2Fdrug-test-offerings%2F&esheet=53554743&newsitemid=20230913825526&lan=en-US&anchor=Drug+testing&index=5&md5=ee6693c14e46e8321efe04fd9476b15e) is used to obtain objective information about patients' recent use of prescription medications and/or illicit drugs and helps monitor the effectiveness of treatment plans. We also conduct real-time tracking of emerging drug use trends (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.millenniumhealth.com%2Fsignalsreport%2F&esheet=53554743&newsitemid=20230913825526&lan=en-US&anchor=drug+use+trends&index=6&md5=2215a5938b8309d7847f09e2835bb65e) to help researchers, public health officials, and policymakers address the significant increase in drug overdose deaths.
Contacts
Jody Schneider
Millennium Health
Jody.Schneider@millenniumhealth.com
619-917-6810
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Contacts
Jody Schneider
Millennium Health
Jody.Schneider@millenniumhealth.com
619-917-6810
Filed Under: Business
0 Comments
Latest on The Californer
- California: Governor Newsom provides $11 million to organizations helping underserved job seekers find training and employment
- For Artificial Intelligence Appreciation Day: Celebrate it with a poem about AI called "Robot Love"
- City of Long Beach Shares Federal Funding Updates and Local Impacts
- The Sessions Studios Secures $300 Million Commitment to Launch World-Class Studio and 15-Film Global Slate
- Fortrea Holdings Inc. (FTRE) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Two themes emerge in Marketing AI
- California: Governor Newsom restructures state government to combat homelessness, boost housing and affordability
- Smart Resnse Unveils Smart Resnse(SRMS) Token-Powered AI Orchestration Platform to Revolutionize Multi-Billion Dollar Market
- Josh and Heidi Follow Up the Much Anticipated and Successful Launch of the "Spreading the Good BUZZ" Podcast with a Personal Request
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- City of Long Beach Opens Applications for Cannabis Equity Program
- Ridgeback Lighting Launches Battery-Free EBL LED Emergency and Egress Light
- Long Beach: Health Department Announces Certification of 32 Community Violence Intervention Workers
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- First Partner highlights apprenticeship program helping underrepresented youth break into careers in California's iconic entertainment industry
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- Cal State LA secures funding for two artificial intelligence projects from CSU
- Colbert Packaging Announces WBENC Recognition